Chao, A. M., Gilden, A., & Wadden, T. A. (2026). Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. PLoS Medicine, 23(1), 1. https://doi.org/10.1371/journal.pmed.1004871
Chicago Style (17th ed.) CitationChao, Ariana M., Adam Gilden, and Thomas A. Wadden. "Glucagon-like Peptide-1 Receptor Agonists for Obesity: Growing Popularity Met with Growing Questions over Safety." PLoS Medicine 23, no. 1 (2026): 1. https://doi.org/10.1371/journal.pmed.1004871.
MLA (9th ed.) CitationChao, Ariana M., et al. "Glucagon-like Peptide-1 Receptor Agonists for Obesity: Growing Popularity Met with Growing Questions over Safety." PLoS Medicine, vol. 23, no. 1, 2026, p. 1, https://doi.org/10.1371/journal.pmed.1004871.